While we principally demonstrate the feasibility of our protocol for the analysis of biomarkers in human serum, future analysis will be needed to evaluate the prognostic value of DcR3 and GDF15 for colon cancer patients using large patient cohorts. Here, TNFRSF6B is linked to malignant colon neoplasm.